Advancements in Hemophilia A Therapies
Steven W. Pipe, MD, explores the latest developments in hemophilia A treatments and prophylactic therapies, including extended half-life agents and a groundbreaking bispecific antibody.
Source: ajmc.com
Recombinant Factor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Recombinant Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Recombinant Factor Today - Breaking & Trending Today
Consequences of Nonadherence in Hemophilia A
Explore the sequelae of nonadherence to prophylactic treatment in hemophilia A and discover strategies for enhancing treatment adherence and overcoming challenges through interdisciplinary collaborations.
Source: ajmc.com
Prophylactic Treatment Challenges and Considerations for Hemophilia A
Allison Wheeler, MD, delves into the complexities of prophylaxis for mild to moderate hemophilia A cases, exploring a patient-centric approach, situational prophylaxis during high-risk activities, and best practices in mitigating joint bleeds.
Source: ajmc.com
Sobi to present new data at EAHAD 2024
Sobi® will present new data at the 17th European Association of Haemophilia and Allied Disorders conference in Frankfurt from 6-9 February 2024. The studies that will be presented support Sobi's...
Source: marketscreener.com
Hemophilia A Treatment Factors and Outcomes
Understand key factors influencing hemophilia A treatment decisions and explore the impact of prophylactic vs on-demand therapy on efficacy, safety, and patient outcomes, including joint health, bleeding episodes, and quality of life in severe cases.
Source: ajmc.com